High Note Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
High Note Wealth's VRTX Position: Q2 2026 in Review
High Note Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, buying an estimated $886 and bringing the position to 95 shares worth $47.2K. The position accounts for 0.01% of the portfolio, ranked #204.
High Note Wealth first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- High Note Wealth held 95 shares of Vertex Pharmaceuticals worth $47.2K as of Q2 2026.
- High Note Wealth bought 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886.
- Vertex Pharmaceuticals made up 0.01% of High Note Wealth's portfolio in Q2 2026, its #204 holding.
- High Note Wealth first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.